Celularity Inc. (CELU)
NASDAQ·Healthcare·Biotechnology
$1.03
+4.04%
Mkt Cap $23.81M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Nov 14, 2025 | — | $5.28M | — | -$1.50 | -$0.88 | +41.33% | — | — |
| Q3 2025 Aug 29, 2025 | — | $11.43M | — | — | -$0.84 | — | — | — |
| Q2 2025 May 8, 2025 | $5.20M | $18.13M | +248.69% | -$1.50 | -$0.59 | +60.67% | — | — |
| Q4 2024 Dec 6, 2024 | $5.30M | $9.30M | +75.40% | -$1.40 | -$0.73 | +47.86% | — | — |
| Q4 2024 Nov 7, 2024 | $4.40M | $12.11M | +175.25% | -$1.40 | -$0.30 | +78.57% | — | — |
| Q3 2024 Sep 27, 2024 | — | $14.68M | — | — | $3.40 | — | — | — |
| Q3 2024 Jul 31, 2024 | $4.71M | $12.11M | +157.26% | — | $0.54 | — | — | — |
| Q1 2024 Jan 2, 2024 | $27.22M | $3.79M | -86.09% | -$0.04 | -$0.60 | -1566.67% | — | — |
| Q3 2023 Aug 14, 2023 | $27.22M | $2.94M | -89.21% | -$0.30 | $3.40 | +1233.33% | — | — |
| Q2 2023 May 22, 2023 | $5.64M | $3.94M | -30.23% | -$2.40 | -$2.20 | +8.33% | — | — |
| Q1 2023 Mar 31, 2023 | $5.48M | $4.13M | -24.65% | -$0.25 | -$0.03 | +88.00% | — | — |
| Q4 2022 Nov 10, 2022 | $5.74M | $4.13M | -27.98% | -$2.60 | $0.30 | +111.54% | — | — |
| Q3 2022 Aug 9, 2022 | $5.44M | $3.78M | -30.56% | -$2.60 | $0.30 | +111.54% | — | — |
| Q2 2022 May 16, 2022 | $5.09M | $5.93M | +16.60% | -$2.30 | -$4.80 | -108.70% | — | — |
| Q1 2022 Mar 31, 2022 | $4.58M | $4.86M | +5.97% | -$2.90 | -$0.30 | +89.66% | — | — |
| Q4 2021 Nov 12, 2021 | $30.37M | $10.62M | -65.02% | -$2.90 | $4.00 | +237.93% | — | — |
| Q3 2021 Aug 16, 2021 | — | $3.20M | — | -$0.16 | -$2.69 | -1581.25% | — | — |
| Q2 2021 May 24, 2021 | — | $2.66M | — | -$0.14 | $2.48 | +1871.43% | — | — |
| Q1 2021 Mar 4, 2021 | — | $3.24M | — | — | $0.64 | — | — | — |
| Q4 2020 Nov 16, 2020 | — | $3.35M | — | — | -$7.56 | — | — | — |